PSEUDOEPHEDRINE HCL

PSEUDOEPHEDRINE HCL was reported 10947 times

PSEUDOEPHEDRINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 1758 0.5508
1 RHEUMATIC FEVER 2365 0.5300
2 HEPATIC ENZYME 78 0.5235
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3642 0.5078
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 329 0.4925
5 LUPUS VULGARIS 587 0.4659
6 RHEUMATOID FACTOR POSITIVE 2577 0.4457
7 DEEP VEIN THROMBOSIS POSTOPERATIVE 873 0.4358
8 PEMPHIGUS 5279 0.4218
9 DUODENAL ULCER PERFORATION 3129 0.4203
10 C-REACTIVE PROTEIN 334 0.3603
11 HAND DEFORMITY 4587 0.3494
12 FACET JOINT SYNDROME 1108 0.3400
13 HYPOCHOLESTEROLAEMIA 119 0.3371
14 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 7 0.3043
15 HELICOBACTER INFECTION 3050 0.2965
16 RETINITIS 508 0.2938
17 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 608 0.2932
18 X-RAY ABNORMAL 501 0.2799
19 DISLOCATION OF VERTEBRA 636 0.2786
20 SWOLLEN JOINT COUNT 65 0.2600
21 PERICARDITIS 4346 0.2584
22 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 143 0.2549
23 MUSCLE INJURY 2074 0.2501
24 PERIPHERAL VENOUS DISEASE 992 0.2427
25 SYNOVITIS 4327 0.2397
26 SERONEGATIVE ARTHRITIS 274 0.2391
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 24 0.2286
28 FOLLICULITIS 2363 0.2251
29 GLOSSODYNIA 4882 0.2178
30 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1403 0.2158
31 GRIP STRENGTH 42 0.1834
32 WOUND 4713 0.1684
33 TENDER JOINT COUNT 14 0.1667
34 C-REACTIVE PROTEIN ABNORMAL 1026 0.1598
35 ACQUIRED PORPHYRIA 11 0.1549
36 SYSTEMIC LUPUS ERYTHEMATOSUS 5402 0.1520
37 BREAST CANCER STAGE III 903 0.1393
38 ONYCHOMADESIS 581 0.1383
39 SCHIZOTYPAL PERSONALITY DISORDER 3 0.1364
40 NAIL OPERATION 56 0.1353
41 DRUG TOLERANCE DECREASED 372 0.1323
42 CONTRAINDICATED PRODUCT ADMINISTERED 3979 0.1313
43 BONE EROSION 463 0.1308
44 LIP DRY 1099 0.1209
45 BLEPHAROSPASM 737 0.1169
46 LIVE BIRTH 927 0.1107
47 PORPHYRIA ACUTE 157 0.1094
48 DEATH NEONATAL 151 0.1085
49 IRRITABLE BOWEL SYNDROME 2302 0.1073
50 OVERLAP SYNDROME 74 0.1057
51 ONYCHOMYCOSIS 455 0.1036
52 WOUND INFECTION 1132 0.1033
53 GRIP STRENGTH DECREASED 901 0.1023
54 HYPERCHOLESTEROLAEMIA 988 0.1022
55 JOINT RANGE OF MOTION DECREASED 1331 0.0991
56 BURSITIS 1144 0.0942
57 AUTOIMMUNE DISORDER 832 0.0853
58 LIVER INJURY 2018 0.0821
59 FIBROMYALGIA 1927 0.0792
60 TYPE 2 DIABETES MELLITUS 2645 0.0785
61 ARTHROPATHY 4305 0.0774
62 IMPAIRED HEALING 2290 0.0697
63 NAIL DISORDER 603 0.0689
64 INFUSION RELATED REACTION 4200 0.0633
65 THERAPEUTIC PRODUCT EFFECT DECREASED 2775 0.0619
66 DISCOMFORT 3765 0.0616
67 INFUSION SITE REACTION 184 0.0615
68 PSORIATIC ARTHROPATHY 2450 0.0603
69 OBESITY 956 0.0599
70 HIP ARTHROPLASTY 886 0.0578
71 JOINT DESTRUCTION 89 0.0572
72 EXOSTOSIS 522 0.0571
73 SCIATICA 903 0.0566
74 HEPATIC ENZYME INCREASED 3858 0.0565
75 MATERNAL EXPOSURE TIMING UNSPECIFIED 208 0.0553
76 BLOOD CHOLESTEROL INCREASED 2470 0.0529
77 LUPUS-LIKE SYNDROME 479 0.0528
78 PRESCRIBED OVERDOSE 1021 0.0527
79 FINGER DEFORMITY 246 0.0507
80 DELUSION OF REPLACEMENT 5 0.0500
81 SWELLING 4666 0.0498
82 RED BLOOD CELL SEDIMENTATION RATE INCREASED 550 0.0497
83 SUDDEN INFANT DEATH SYNDROME 24 0.0488
84 PULMONARY FIBROSIS 934 0.0486
85 WALKING AID USER 318 0.0482
86 BLISTER 2617 0.0466
87 RHEUMATOID ARTHRITIS 5279 0.0464
88 LOWER LIMB FRACTURE 870 0.0452
89 LOWER RESPIRATORY TRACT INFECTION 2025 0.0445
90 EYE INJURY 133 0.0437
91 MATERNAL EXPOSURE DURING PREGNANCY 3902 0.0437
92 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 7 0.0435
93 VAGINAL FLATULENCE 13 0.0429
94 MUSCULOSKELETAL DEFORMITY 10 0.0427
95 PRODUCT LABEL CONFUSION 247 0.0423
96 PUSTULAR PSORIASIS 144 0.0419
97 BREAST CANCER STAGE II 345 0.0414
98 ULCER HAEMORRHAGE 275 0.0406
99 PRESCRIBED UNDERDOSE 801 0.0401
100 SPONDYLITIS 146 0.0401
101 DRUG INTOLERANCE 3819 0.0395
102 BACK INJURY 424 0.0389
103 JOINT DISLOCATION 412 0.0389
104 KNEE ARTHROPLASTY 820 0.0389
105 TREATMENT FAILURE 3062 0.0369
106 STOMATITIS 2202 0.0363
107 FOOT DEFORMITY 398 0.0359
108 RED BLOOD CELL SEDIMENTATION RATE 10 0.0358
109 CONGENITAL ANOMALY 275 0.0355
110 GAIT INABILITY 1178 0.0352
111 JOINT SWELLING 4060 0.0336
112 TASTE DISORDER 681 0.0335
113 COELIAC DISEASE 324 0.0330
114 NIGHT SWEATS 1061 0.0329
115 OSTEOARTHRITIS 1331 0.0314
116 ABDOMINAL DISCOMFORT 5195 0.0309
117 ANTIPHOSPHOLIPID ANTIBODIES 6 0.0308
118 RASH VESICULAR 141 0.0291
119 MOBILITY DECREASED 2088 0.0290
120 C-REACTIVE PROTEIN INCREASED 1039 0.0285
121 INJURY 1999 0.0284
122 WHEEZING 1678 0.0283
123 MUSCULOSKELETAL STIFFNESS 2476 0.0282
124 ILL-DEFINED DISORDER 1626 0.0267
125 NORMAL NEWBORN 145 0.0266
126 DRUG TOLERANCE 133 0.0263
127 PERFORATION 21 0.0261
128 ALOPECIA 5066 0.0258
129 SPINAL FUSION SURGERY 103 0.0254
130 GENERAL PHYSICAL HEALTH DETERIORATION 2931 0.0253
131 EXPOSURE DURING PREGNANCY 1558 0.0250
132 LIVER FUNCTION TEST INCREASED 534 0.0248
133 HEPATIC CIRRHOSIS 459 0.0244
134 INTENTIONAL PRODUCT USE ISSUE 2114 0.0241
135 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 400 0.0233
136 ROAD TRAFFIC ACCIDENT 964 0.0230
137 EPILEPSY 690 0.0225
138 OEDEMA 1223 0.0225
139 LUNG DISORDER 1101 0.0224
140 INFLAMMATION 1142 0.0221
141 ANKLE ARTHROPLASTY 8 0.0220
142 SLEEP DISORDER 1508 0.0213
143 HYPERSENSITIVITY 3952 0.0213
144 BLOOD CHOLESTEROL 10 0.0211
145 ANAL INFLAMMATION 13 0.0203
146 PREGNANCY 394 0.0197
147 GASTROINTESTINAL DISORDER 1736 0.0194
148 THERAPY NON-RESPONDER 871 0.0194
149 SARS-COV-2 TEST NEGATIVE 13 0.0193
150 JOINT STIFFNESS 488 0.0186
151 MUSCULOSKELETAL PAIN 974 0.0186
152 EPIDERMAL NECROSIS 18 0.0185
153 PRODUCT USE ISSUE 3450 0.0183
154 DELIRIUM 637 0.0183
155 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 42 0.0182
156 RHEUMATOID VASCULITIS 4 0.0178
157 SINUSITIS 1780 0.0174
158 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 9 0.0172
159 LIVER DISORDER 749 0.0169
160 DELUSIONAL PERCEPTION 7 0.0169
161 GENERAL SYMPTOM 124 0.0165
162 DRY MOUTH 1298 0.0160
163 CONTUSION 1528 0.0159
164 MYOSITIS 141 0.0157
165 ADVERSE REACTION 208 0.0157
166 ANOXIC ENCEPHALOPATHY 10 0.0155
167 DRUG-INDUCED LIVER INJURY 482 0.0153
168 THUNDERCLAP HEADACHE 4 0.0153
169 POLYARTHRITIS 79 0.0150
170 DISABILITY 294 0.0149
171 CONFUSIONAL STATE 2245 0.0139
172 EAR INFECTION 368 0.0138
173 PERIPHERAL SWELLING 2128 0.0138
174 INFECTION 1982 0.0137
175 HYPOAESTHESIA 1954 0.0130
176 CARCINOID TUMOUR PULMONARY 3 0.0124
177 REPETITIVE SPEECH 7 0.0124
178 VASCULAR ACCESS COMPLICATION 10 0.0123
179 CYCLIC VOMITING SYNDROME 9 0.0123
180 EAR PAIN 239 0.0123
181 MIGRAINE 1159 0.0121
182 PARANASAL SINUS HYPOSECRETION 3 0.0120
183 NASOPHARYNGITIS 2186 0.0118
184 ADVERSE EVENT 1082 0.0117
185 DRUG INTERACTION POTENTIATION 3 0.0116
186 CHILD ABUSE 3 0.0116
187 HYPERTENSION 2410 0.0114
188 OSTEOPOROSIS 464 0.0113
189 FEMALE GENITAL TRACT FISTULA 19 0.0111
190 URTICARIA 1861 0.0111
191 DYSPEPSIA 1083 0.0110
192 TENOSYNOVITIS STENOSANS 6 0.0108
193 MEAN PLATELET VOLUME DECREASED 9 0.0107
194 DAIRY INTOLERANCE 3 0.0107
195 RASH 4635 0.0106
196 ADMINISTRATION SITE DISCOMFORT 2 0.0106
197 WEIGHT INCREASED 2327 0.0104
198 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 734 0.0103
199 ADVERSE DRUG REACTION 904 0.0101
200 GASTROOESOPHAGEAL REFLUX DISEASE 810 0.0101
201 CONDITION AGGRAVATED 2905 0.0095
202 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 453 0.0094
203 HEPATITIS 238 0.0093
204 BRONCHIAL OBSTRUCTION 13 0.0093
205 AMNESIA 594 0.0091
206 MEDICATION ERROR 505 0.0091
207 JOINT ARTHROPLASTY 16 0.0089
208 RESPIRATORY DISORDER 265 0.0088
209 SYNOVIAL DISORDER 4 0.0088
210 CAROTID ARTERY ANEURYSM 3 0.0088
211 PAIN 5386 0.0088
212 VICTIM OF HOMICIDE 5 0.0086
213 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 144 0.0085
214 MEMORY IMPAIRMENT 1149 0.0084
215 OESOPHAGEAL MOTILITY DISORDER 3 0.0083
216 FREQUENT BOWEL MOVEMENTS 219 0.0081
217 ASTHMA 915 0.0081
218 HYPERTRANSAMINASAEMIA 56 0.0080
219 SUSPECTED OFF LABEL USE 36 0.0080
220 ABDOMINAL PAIN UPPER 1597 0.0077
221 NECK PAIN 426 0.0076
222 ARTHRALGIA 3158 0.0076
223 RADICULOPATHY 20 0.0076
224 MUSCULAR WEAKNESS 854 0.0075
225 CRANIOTOMY 3 0.0073
226 PRODUCT USE IN UNAPPROVED INDICATION 1792 0.0072
227 EXPOSURE TO TOXIC AGENT 23 0.0072
228 OCCIPITAL NEURALGIA 4 0.0071
229 UPPER RESPIRATORY TRACT INFECTION 326 0.0070
230 BACK DISORDER 114 0.0070
231 DECREASED APPETITE 1620 0.0070
232 WEIGHT FLUCTUATION 70 0.0067
233 PARAESTHESIA 1046 0.0066
234 ADRENAL INSUFFICIENCY 79 0.0065
235 MITE ALLERGY 4 0.0061
236 FATIGUE 4723 0.0061
237 CHEST PAIN 1099 0.0059
238 OEDEMA PERIPHERAL 720 0.0059
239 VITAMIN B12 DECREASED 17 0.0059
240 MEAN CELL VOLUME DECREASED 9 0.0058
241 MYCOBACTERIAL INFECTION 10 0.0058
242 UNDERDOSE 409 0.0056
243 PYREXIA 1930 0.0056
244 DRUG TOXICITY 75 0.0055
245 IMMUNODEFICIENCY 82 0.0055
246 INCREASED BRONCHIAL SECRETION 14 0.0055
247 MUSCLE SPASMS 1003 0.0055
248 MEAN CELL HAEMOGLOBIN DECREASED 10 0.0055
249 MUSCLE SPASTICITY 67 0.0054
250 CEREBRAL VASOCONSTRICTION 4 0.0054
251 CHRONIC SINUSITIS 20 0.0053
252 INJECTION SITE REACTION 364 0.0053
253 ARTHRITIS 401 0.0051
254 PROCTITIS 14 0.0050
255 INCORRECT PRODUCT ADMINISTRATION DURATION 108 0.0050
256 GAIT DISTURBANCE 951 0.0050
257 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 4 0.0049
258 EXCESSIVE CERUMEN PRODUCTION 3 0.0048
259 DEPRESSION 1100 0.0048
260 PRODUCT QUALITY ISSUE 656 0.0048
261 COLITIS ULCERATIVE 212 0.0047
262 THERAPEUTIC RESPONSE DECREASED 286 0.0047
263 INSOMNIA 1243 0.0047
264 PAIN IN EXTREMITY 1366 0.0046
265 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
266 PRURITUS 1762 0.0046
267 VOMITING 2120 0.0045
268 VISUAL IMPAIRMENT 556 0.0045
269 MACULAR DEGENERATION 53 0.0044
270 MATERNAL EXPOSURE BEFORE PREGNANCY 30 0.0044
271 ALLERGY TO PLANTS 2 0.0044
272 PNEUMONIA 1418 0.0044
273 RECTAL HAEMORRHAGE 183 0.0043
274 OFF LABEL USE 3714 0.0042
275 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 11 0.0041
276 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 8 0.0040
277 DRUG INEFFECTIVE 5335 0.0040
278 MULTIPLE DRUG OVERDOSE 20 0.0040
279 CARDIAC INFECTION 3 0.0040
280 HEADACHE 2403 0.0038
281 MALAISE 1626 0.0037
282 MULTIPLE ALLERGIES 29 0.0037
283 ALTERED VISUAL DEPTH PERCEPTION 3 0.0037
284 MONOCYTE COUNT INCREASED 13 0.0036
285 FEELING HOT 219 0.0036
286 CRYPTORCHISM 4 0.0036
287 INFECTED BITE 3 0.0035
288 ALLERGIC SINUSITIS 3 0.0035
289 DIZZINESS 1721 0.0034
290 VASOCONSTRICTION 3 0.0034
291 ASTHENIA 1288 0.0034
292 DUODENAL ULCER 24 0.0034
293 HYPERTENSIVE EMERGENCY 4 0.0034
294 DYSPNOEA 1893 0.0033
295 DRUG SCREEN POSITIVE 26 0.0033
296 ASPARTATE AMINOTRANSFERASE ABNORMAL 5 0.0033
297 ABDOMINAL PAIN 750 0.0032
298 SKIN TEST POSITIVE 3 0.0032
299 FOETAL EXPOSURE DURING PREGNANCY 260 0.0032
300 HEPATIC CONGESTION 3 0.0032
301 NODULE 40 0.0031
302 DUST ALLERGY 3 0.0031
303 TACHYCARDIA 266 0.0030
304 PSORIASIS 388 0.0030
305 STARING 7 0.0029
306 ABDOMINAL DISTENSION 302 0.0029
307 MENISCUS LESION 4 0.0029
308 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
309 LABORATORY TEST ABNORMAL 83 0.0028
310 DIARRHOEA 1808 0.0028
311 BODY TEMPERATURE INCREASED 56 0.0027
312 WEIGHT DECREASED 758 0.0027
313 FLUID RETENTION 138 0.0027
314 PANCREATITIS 143 0.0027
315 NEPHROSCLEROSIS 3 0.0027
316 WHITE BLOOD CELL COUNT INCREASED 103 0.0027
317 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 7 0.0027
318 BRONCHITIS 190 0.0026
319 ANXIETY 722 0.0025
320 TINEA PEDIS 4 0.0025
321 TOXIC EPIDERMAL NECROLYSIS 38 0.0025
322 SCLERITIS 4 0.0025
323 MULTIPLE DRUG OVERDOSE INTENTIONAL 8 0.0025
324 NAUSEA 1931 0.0024
325 GASTROENTERITIS VIRAL 44 0.0024
326 SEBORRHOEIC DERMATITIS 4 0.0024
327 ADRENAL MASS 2 0.0024
328 PROCTALGIA 15 0.0023
329 PUPIL FIXED 4 0.0023
330 OTORRHOEA 4 0.0023
331 ANGIONEUROTIC OEDEMA 6 0.0022
332 HAEMORRHAGIC DIATHESIS 8 0.0022
333 SCHIZOAFFECTIVE DISORDER 4 0.0022
334 HYPERVENTILATION 13 0.0022
335 PNEUMONIA VIRAL 7 0.0022
336 ASPIRATION 24 0.0022
337 CONDUCTION DISORDER 4 0.0022
338 JOINT EFFUSION 15 0.0022
339 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
340 INTENTIONAL MISUSE 4 0.0021
341 RASH PRURITIC 113 0.0021
342 SCREAMING 13 0.0020
343 PHYSICAL DISABILITY 9 0.0020
344 HYPOCALCAEMIA 38 0.0020
345 VENTRICULAR HYPERTROPHY 5 0.0020
346 RHINITIS 16 0.0020
347 BLOOD PRESSURE DIASTOLIC INCREASED 9 0.0019
348 EYE ALLERGY 3 0.0019
349 PROTEIN TOTAL INCREASED 5 0.0019
350 TREATMENT NONCOMPLIANCE 102 0.0019
351 HOSPITALISATION 286 0.0019
352 SYMPTOM RECURRENCE 11 0.0018
353 CLONUS 5 0.0018
354 SPINAL CORD DISORDER 3 0.0018
355 FOOT OPERATION 9 0.0018
356 COLONIC POLYP 3 0.0018
357 HYPOKALAEMIA 83 0.0018
358 WRONG DRUG ADMINISTERED 16 0.0018
359 CORNEAL OEDEMA 4 0.0018
360 MOVEMENT DISORDER 57 0.0018
361 PERIARTHRITIS 4 0.0018
362 BLOOD PH DECREASED 3 0.0018
363 BRONCHOPNEUMONIA 6 0.0018
364 CERVICAL SPINAL STENOSIS 3 0.0017
365 RESPIRATORY TRACT INFECTION 44 0.0017
366 VAGINAL DISCHARGE 17 0.0017
367 URINARY HESITATION 4 0.0017
368 URINE FLOW DECREASED 4 0.0017
369 CEREBROVASCULAR DISORDER 5 0.0017
370 JAW DISORDER 9 0.0016
371 CONTRAST MEDIA ALLERGY 3 0.0016
372 ULCER 26 0.0016
373 ANAPHYLACTIC REACTION 89 0.0016
374 ALLERGY TO CHEMICALS 2 0.0016
375 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
376 ACCIDENT 19 0.0016
377 NARCOLEPSY 3 0.0016
378 PARANASAL SINUS DISCOMFORT 6 0.0016
379 LEUKOPENIA 79 0.0016
380 EXCORIATION 4 0.0016
381 WHEELCHAIR USER 7 0.0016
382 SKIN REACTION 22 0.0016
383 ADJUSTMENT DISORDER 2 0.0015
384 ARTHRITIS INFECTIVE 7 0.0015
385 BLOOD SODIUM INCREASED 4 0.0015
386 RASH PAPULAR 33 0.0015
387 ACCIDENTAL POISONING 2 0.0015
388 TONGUE BITING 3 0.0015
389 RHEUMATOID NODULE 4 0.0015
390 TENOSYNOVITIS 4 0.0014
391 PLEURITIC PAIN 4 0.0014
392 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
393 PRE-EXISTING CONDITION IMPROVED 9 0.0014
394 TENDERNESS 15 0.0014
395 PARAESTHESIA ORAL 20 0.0014
396 DYSPHORIA 7 0.0014
397 OESOPHAGEAL VARICES HAEMORRHAGE 3 0.0014
398 MIDDLE EAR EFFUSION 3 0.0014
399 LIMB DISCOMFORT 42 0.0014
400 RHINITIS ALLERGIC 6 0.0013
401 BLOOD CULTURE POSITIVE 4 0.0013
402 BRONCHIECTASIS 9 0.0013
403 PREGNANCY AFTER POST COITAL CONTRACEPTION 3 0.0013
404 ORAL CANDIDIASIS 17 0.0013
405 DRUG EFFECT LESS THAN EXPECTED 19 0.0013
406 CUSHINGOID 4 0.0012
407 APPETITE DISORDER 8 0.0012
408 INTRAVENTRICULAR HAEMORRHAGE 3 0.0012
409 SEASONAL ALLERGY 17 0.0012
410 THERAPEUTIC AGENT TOXICITY 4 0.0012
411 DEFORMITY 11 0.0012
412 BLOOD CHLORIDE DECREASED 3 0.0012
413 ACUTE SINUSITIS 2 0.0012
414 PRIAPISM 4 0.0012
415 FEELING JITTERY 22 0.0012
416 RETINAL DISORDER 3 0.0012
417 ACCIDENTAL OVERDOSE 42 0.0011
418 OVERDOSE 244 0.0011
419 UNRESPONSIVE TO STIMULI 29 0.0011
420 ALCOHOL POISONING 3 0.0011
421 POISONING 14 0.0011
422 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 61 0.0011
423 GAMBLING DISORDER 3 0.0011
424 CLUMSINESS 3 0.0011
425 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
426 COMPLETED SUICIDE 91 0.0011
427 RHINALGIA 3 0.0011
428 ALCOHOL USE 4 0.0011
429 BREAST CANCER STAGE I 10 0.0011
430 OBSTRUCTIVE AIRWAYS DISORDER 12 0.0011
431 PLATELET COUNT INCREASED 14 0.0011
432 INTENTIONAL PRODUCT MISUSE 94 0.0011
433 SPINAL DISORDER 10 0.0011
434 VISUAL DISTURBANCE 6 0.0010
435 POST-TRAUMATIC STRESS DISORDER 7 0.0010
436 COLITIS ISCHAEMIC 7 0.0010
437 ATELECTASIS 10 0.0010
438 OPTIC ISCHAEMIC NEUROPATHY 4 0.0010
439 APNOEA 8 0.0010
440 SNEEZING 23 0.0010
441 HAEMORRHOIDS 20 0.0010
442 CONJUNCTIVITIS 19 0.0010
443 LOSS OF CONSCIOUSNESS 131 0.0010
444 MIDDLE INSOMNIA 19 0.0010
445 ENERGY INCREASED 6 0.0010
446 RESPIRATORY RATE INCREASED 9 0.0010
447 CREPITATIONS 3 0.0010
448 ARTERIOSPASM CORONARY 4 0.0010
449 CENTRAL VENOUS CATHETERISATION 3 0.0010
450 SEPTIC SHOCK 43 0.0010
451 MASTICATION DISORDER 3 0.0010
452 RESPIRATORY ARREST 27 0.0010
453 THINKING ABNORMAL 18 0.0010
454 MAJOR DEPRESSION 7 0.0010
455 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
456 SLEEP APNOEA SYNDROME 18 0.0009
457 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
458 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
459 FALL 299 0.0009
460 PLANTAR FASCIITIS 3 0.0009
461 DIABETES MELLITUS 68 0.0009
462 SINUS CONGESTION 12 0.0009
463 WRONG PRODUCT ADMINISTERED 6 0.0009
464 IMPAIRED DRIVING ABILITY 10 0.0009
465 ABDOMINAL HERNIA 4 0.0009
466 GASTRIC DISORDER 30 0.0009
467 EAR DISORDER 4 0.0009
468 GRANULOMA 3 0.0009
469 SYNOVIAL CYST 4 0.0009
470 TACHYPHRENIA 3 0.0009
471 SKIN WARM 5 0.0009
472 EOSINOPHILIA 15 0.0009
473 THROMBOTIC THROMBOCYTOPENIC PURPURA 3 0.0009
474 DIVERTICULUM 6 0.0008
475 SINUS HEADACHE 5 0.0008
476 URINARY RETENTION 28 0.0008
477 FRUSTRATION 3 0.0008
478 GASTROINTESTINAL TOXICITY 4 0.0008
479 SCLERODERMA 3 0.0008
480 THROMBOCYTOPENIA 92 0.0008
481 RASH ERYTHEMATOUS 39 0.0008
482 DIABETIC NEUROPATHY 4 0.0008
483 ANEURYSM 4 0.0008
484 HEPATIC ENZYME ABNORMAL 4 0.0008
485 PHOTOPHOBIA 15 0.0008
486 SNORING 3 0.0008
487 PHLEBITIS 4 0.0008
488 PERIPHERAL VASCULAR DISORDER 4 0.0008
489 ACTINIC KERATOSIS 2 0.0008
490 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
491 PROSTATOMEGALY 3 0.0008
492 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
493 PULMONARY CONGESTION 10 0.0008
494 OBSESSIVE-COMPULSIVE DISORDER 6 0.0007
495 CHOLECYSTITIS CHRONIC 5 0.0007
496 ABDOMINAL MASS 2 0.0007
497 GINGIVITIS 4 0.0007
498 HOMICIDAL IDEATION 3 0.0007
499 PLEURAL EFFUSION 45 0.0007
500 SELF-MEDICATION 3 0.0007
501 PERIPHERAL COLDNESS 10 0.0007
502 EXPIRED PRODUCT ADMINISTERED 24 0.0007
503 INTENTIONAL DRUG MISUSE 15 0.0007
504 PRODUCTIVE COUGH 34 0.0007
505 PERIORBITAL SWELLING 4 0.0007
506 PULMONARY TOXICITY 5 0.0007
507 POOR QUALITY SLEEP 15 0.0007
508 MUSCLE STRAIN 6 0.0007
509 CARDIO-RESPIRATORY ARREST 29 0.0007
510 HORDEOLUM 3 0.0007
511 NERVOUSNESS 36 0.0007
512 EUPHORIC MOOD 7 0.0007
513 DECREASED INTEREST 4 0.0007
514 BLOOD CREATINE INCREASED 3 0.0007
515 MENINGITIS ASEPTIC 3 0.0007
516 DRUG LEVEL INCREASED 11 0.0007
517 NASAL CONGESTION 39 0.0007
518 RESTLESS LEGS SYNDROME 12 0.0007
519 ECONOMIC PROBLEM 10 0.0007
520 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
521 BODY HEIGHT DECREASED 7 0.0007
522 DRUG ABUSER 4 0.0007
523 NEPHROGENIC ANAEMIA 3 0.0006
524 OESOPHAGITIS 7 0.0006
525 NASAL DRYNESS 4 0.0006
526 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
527 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
528 PALPITATIONS 72 0.0006
529 PROCEDURAL PAIN 17 0.0006
530 BODY TEMPERATURE DECREASED 6 0.0006
531 NASAL POLYPS 3 0.0006
532 EYELID OEDEMA 7 0.0006
533 OSTEOPENIA 9 0.0006
534 DYSLIPIDAEMIA 3 0.0006
535 HEPATOTOXICITY 13 0.0006
536 CEREBRAL ISCHAEMIA 3 0.0006
537 STOMACH DISCOMFORT 3 0.0006
538 RESPIRATION ABNORMAL 4 0.0006
539 LYMPHOEDEMA 4 0.0006
540 PETECHIAE 6 0.0006
541 CATATONIA 3 0.0006
542 SPINAL OSTEOARTHRITIS 5 0.0006
543 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
544 DYSURIA 20 0.0005
545 ARTHROPOD BITE 4 0.0005
546 ACUTE PULMONARY OEDEMA 3 0.0005
547 MITRAL VALVE INCOMPETENCE 6 0.0005
548 DERMATITIS CONTACT 6 0.0005
549 INCORRECT DOSE ADMINISTERED 120 0.0005
550 DISEASE RECURRENCE 25 0.0005
551 NEUROLOGICAL SYMPTOM 3 0.0005
552 NO ADVERSE EVENT 94 0.0005
553 INFLAMMATORY BOWEL DISEASE 5 0.0005
554 URINE ODOUR ABNORMAL 3 0.0005
555 DEEP VEIN THROMBOSIS 33 0.0005
556 ERECTILE DYSFUNCTION 13 0.0005
557 NASAL DISCOMFORT 4 0.0005
558 TRICUSPID VALVE INCOMPETENCE 4 0.0005
559 COLITIS 19 0.0005
560 CARPAL TUNNEL SYNDROME 7 0.0005
561 INCORRECT DRUG ADMINISTRATION DURATION 14 0.0005
562 TOOTHACHE 9 0.0005
563 SEDATION 13 0.0005
564 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0005
565 BLOOD POTASSIUM INCREASED 8 0.0005
566 TOOTH ABSCESS 5 0.0005
567 EMOTIONAL DISORDER 15 0.0005
568 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
569 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
570 EYE DISCHARGE 5 0.0005
571 ACCIDENTAL EXPOSURE 2 0.0005
572 AGITATION 35 0.0005
573 PHOTOPSIA 3 0.0005
574 CARDIAC ARREST 39 0.0005
575 ABSCESS LIMB 2 0.0005
576 ALCOHOLISM 2 0.0005
577 HYSTERECTOMY 4 0.0005
578 TENDON DISORDER 3 0.0005
579 SOMNAMBULISM 3 0.0005
580 BACK PAIN 106 0.0005
581 ANKLE FRACTURE 7 0.0005
582 BLOOD PRESSURE INCREASED 69 0.0005
583 HALLUCINATION 34 0.0005
584 BREAST MASS 3 0.0004
585 THERAPEUTIC RESPONSE UNEXPECTED 20 0.0004
586 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 80 0.0004
587 PSYCHOTIC DISORDER 13 0.0004
588 IMPAIRED GASTRIC EMPTYING 6 0.0004
589 AKATHISIA 6 0.0004
590 HAEMOGLOBIN DECREASED 45 0.0004
591 HAEMATOCHEZIA 24 0.0004
592 GRAND MAL CONVULSION 4 0.0004
593 DRUG ABUSE 36 0.0004
594 ERYTHEMA MULTIFORME 4 0.0004
595 FLANK PAIN 4 0.0004
596 HALLUCINATION, VISUAL 9 0.0004
597 HAND FRACTURE 3 0.0004
598 TOXICITY TO VARIOUS AGENTS 71 0.0004
599 IMPAIRED WORK ABILITY 9 0.0004
600 HYPERLIPIDAEMIA 5 0.0004
601 BLOOD UREA INCREASED 7 0.0004
602 SEROTONIN SYNDROME 8 0.0004
603 VISUAL FIELD DEFECT 3 0.0004
604 CARDIOMEGALY 5 0.0004
605 SMALL INTESTINAL OBSTRUCTION 5 0.0004
606 SPINAL OPERATION 5 0.0004
607 INTENTIONAL OVERDOSE 26 0.0004
608 HIP FRACTURE 13 0.0004
609 SINUS DISORDER 8 0.0004
610 PHARYNGITIS 5 0.0004
611 BLADDER DISORDER 4 0.0004
612 ORAL PAIN 9 0.0004
613 HYDRONEPHROSIS 3 0.0004
614 HYPOTONIA 4 0.0004
615 SECRETION DISCHARGE 5 0.0004
616 PAROSMIA 3 0.0004
617 COLD SWEAT 7 0.0004
618 DRUG ERUPTION 7 0.0004
619 DRY THROAT 4 0.0004
620 INTERSTITIAL LUNG DISEASE 19 0.0004
621 SLUGGISHNESS 4 0.0004
622 GALLBLADDER DISORDER 7 0.0004
623 THIRST 7 0.0004
624 PROCEDURAL COMPLICATION 3 0.0004
625 MUSCLE TWITCHING 9 0.0004
626 TEMPERATURE INTOLERANCE 4 0.0004
627 RHINORRHOEA 25 0.0004
628 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
629 HIATUS HERNIA 5 0.0004
630 HAEMORRHAGIC STROKE 3 0.0004
631 PANIC ATTACK 14 0.0004
632 BRAIN FOG 6 0.0004
633 TOOTH INFECTION 5 0.0004
634 FURUNCLE 3 0.0004
635 BLOOD ALBUMIN DECREASED 3 0.0004
636 SUDDEN DEATH 4 0.0004
637 CYSTITIS 12 0.0004
638 BLOOD DISORDER 3 0.0004
639 DEATH 320 0.0004
640 PULMONARY THROMBOSIS 4 0.0004
641 POLYURIA 3 0.0004
642 HICCUPS 3 0.0004
643 SKIN LESION 10 0.0004
644 ABNORMAL DREAMS 10 0.0004
645 MENTAL STATUS CHANGES 10 0.0004
646 NERVE INJURY 4 0.0004
647 HYPERTENSIVE CRISIS 4 0.0004
648 HYPOTENSION 72 0.0004
649 PULMONARY OEDEMA 16 0.0004
650 COMA 17 0.0004
651 SENSATION OF FOREIGN BODY 3 0.0004
652 BLOOD CALCIUM DECREASED 4 0.0004
653 CANDIDA INFECTION 6 0.0004
654 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
655 WHITE BLOOD CELL COUNT DECREASED 38 0.0004
656 MICTURITION URGENCY 4 0.0003
657 CHOLECYSTECTOMY 4 0.0003
658 SOMNOLENCE 70 0.0003
659 CARDIAC MURMUR 3 0.0003
660 SUICIDE ATTEMPT 21 0.0003
661 PYELONEPHRITIS 3 0.0003
662 ELECTROLYTE IMBALANCE 4 0.0003
663 HEART RATE INCREASED 34 0.0003
664 SPINAL PAIN 4 0.0003
665 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
666 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
667 HEAD DISCOMFORT 6 0.0003
668 ATAXIA 4 0.0003
669 CHOLELITHIASIS 11 0.0003
670 ANAL INCONTINENCE 3 0.0003
671 OSTEOMYELITIS 6 0.0003
672 END STAGE RENAL DISEASE 6 0.0003
673 JOINT INJURY 7 0.0003
674 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 17 0.0003
675 IRON DEFICIENCY ANAEMIA 3 0.0003
676 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
677 CHILLS 38 0.0003
678 FEELING COLD 9 0.0003
679 PERSONALITY CHANGE 3 0.0003
680 HEPATIC STEATOSIS 6 0.0003
681 DELUSION 5 0.0003
682 DIARRHOEA HAEMORRHAGIC 3 0.0003
683 EXTRA DOSE ADMINISTERED 13 0.0003
684 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
685 AGGRESSION 16 0.0003
686 DERMATITIS ALLERGIC 4 0.0003
687 HALLUCINATION, AUDITORY 5 0.0003
688 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
689 HYPERSOMNIA 9 0.0003
690 CHEST DISCOMFORT 32 0.0003
691 MYDRIASIS 4 0.0003
692 VERTIGO 19 0.0003
693 ILLNESS 32 0.0003
694 SINUS BRADYCARDIA 3 0.0003
695 SKIN ULCER 8 0.0003
696 DIZZINESS POSTURAL 3 0.0003
697 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
698 HEPATOMEGALY 3 0.0003
699 ANHEDONIA 8 0.0003
700 MANIA 5 0.0003
701 LIGAMENT SPRAIN 3 0.0003
702 STAPHYLOCOCCAL INFECTION 10 0.0003
703 VENTRICULAR TACHYCARDIA 5 0.0003
704 HAEMATOCRIT DECREASED 6 0.0003
705 RESPIRATORY FAILURE 22 0.0003
706 RESTLESSNESS 11 0.0003
707 DRY EYE 15 0.0003
708 FUNGAL INFECTION 10 0.0003
709 DISTURBANCE IN ATTENTION 16 0.0003
710 COUGH 83 0.0003
711 ARRHYTHMIA 14 0.0003
712 EYELID PTOSIS 3 0.0003
713 SUBARACHNOID HAEMORRHAGE 3 0.0003
714 PALLOR 8 0.0003
715 ACUTE HEPATIC FAILURE 4 0.0003
716 EAR DISCOMFORT 3 0.0003
717 PARANOIA 5 0.0003
718 CONSTIPATION 63 0.0003
719 UNINTENDED PREGNANCY 3 0.0003
720 FEBRILE NEUTROPENIA 19 0.0003
721 SCRATCH 3 0.0003
722 FEELING ABNORMAL 68 0.0003
723 DEPRESSED MOOD 15 0.0003
724 RENAL PAIN 3 0.0003
725 TINNITUS 13 0.0003
726 CONVULSION 16 0.0003
727 CARDIOGENIC SHOCK 4 0.0003
728 MYALGIA 47 0.0003
729 HAEMATEMESIS 7 0.0003
730 BIPOLAR DISORDER 3 0.0003
731 HYPERGLYCAEMIA 10 0.0003
732 EYE DISORDER 9 0.0003
733 DENTAL CARIES 3 0.0003
734 BLOOD GLUCOSE ABNORMAL 5 0.0003
735 CARDIOMYOPATHY 4 0.0003
736 URINARY INCONTINENCE 8 0.0003
737 SKIN INFECTION 3 0.0003
738 ANGER 9 0.0003
739 TREMOR 44 0.0003
740 LACRIMATION INCREASED 8 0.0003
741 CORONARY ARTERY DISEASE 8 0.0003
742 FOOT FRACTURE 5 0.0003
743 MYOCARDIAL ISCHAEMIA 3 0.0003
744 MUSCULOSKELETAL DISORDER 5 0.0003
745 ACIDOSIS 2 0.0003
746 LETHARGY 15 0.0003
747 BLOOD CREATININE INCREASED 17 0.0003
748 RENAL FAILURE ACUTE 11 0.0003
749 TENDONITIS 4 0.0003
750 BASAL CELL CARCINOMA 4 0.0003
751 CHOKING 5 0.0003
752 SWOLLEN TONGUE 8 0.0003
753 HYPOXIA 9 0.0003
754 AFFECTIVE DISORDER 2 0.0003
755 CYANOSIS 4 0.0003
756 DIVERTICULITIS 7 0.0003
757 DISORIENTATION 10 0.0003
758 RESPIRATORY TRACT CONGESTION 4 0.0003
759 WRIST FRACTURE 3 0.0003
760 BLOOD PRESSURE FLUCTUATION 6 0.0002
761 IRRITABILITY 15 0.0002
762 HAEMORRHAGE 26 0.0002
763 HYPERHIDROSIS 32 0.0002
764 PRODUCT ADMINISTRATION ERROR 5 0.0002
765 PAIN IN JAW 7 0.0002
766 MUSCLE TIGHTNESS 4 0.0002
767 NEURALGIA 6 0.0002
768 NO THERAPEUTIC RESPONSE 3 0.0002
769 SWELLING FACE 16 0.0002
770 THROAT IRRITATION 11 0.0002
771 RED BLOOD CELL COUNT DECREASED 7 0.0002
772 ANGINA PECTORIS 7 0.0002
773 DYSGEUSIA 18 0.0002
774 PULMONARY EMBOLISM 23 0.0002
775 ILEUS 3 0.0002
776 SUICIDAL IDEATION 22 0.0002
777 POLLAKIURIA 10 0.0002
778 DYSARTHRIA 9 0.0002
779 DERMATITIS 5 0.0002
780 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
781 BRAIN OEDEMA 3 0.0002
782 ABDOMINAL PAIN LOWER 6 0.0002
783 HEMIPARESIS 4 0.0002
784 SCAR 4 0.0002
785 ROTATOR CUFF SYNDROME 3 0.0002
786 ERYTHEMA 48 0.0002
787 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
788 DYSPHAGIA 22 0.0002
789 NIGHTMARE 8 0.0002
790 DIPLOPIA 6 0.0002
791 EYE PAIN 13 0.0002
792 FLATULENCE 13 0.0002
793 HEART RATE DECREASED 8 0.0002
794 ASPARTATE AMINOTRANSFERASE INCREASED 12 0.0002
795 NERVOUS SYSTEM DISORDER 7 0.0002
796 ISCHAEMIC STROKE 4 0.0002
797 CHRONIC KIDNEY DISEASE 17 0.0002
798 BONE DENSITY DECREASED 7 0.0002
799 JAUNDICE 6 0.0002
800 ELECTROCARDIOGRAM QT PROLONGED 8 0.0002
801 HYPOTHYROIDISM 7 0.0002
802 VISION BLURRED 30 0.0002
803 RENAL FAILURE 29 0.0002
804 CELLULITIS 11 0.0002
805 SHOCK 5 0.0002
806 EYE SWELLING 8 0.0002
807 APHONIA 3 0.0002
808 BACTERIAL INFECTION 4 0.0002
809 BLOOD TEST ABNORMAL 3 0.0002
810 BLINDNESS UNILATERAL 3 0.0002
811 ABORTION INDUCED 2 0.0002
812 DYSPNOEA EXERTIONAL 8 0.0002
813 INTESTINAL OBSTRUCTION 8 0.0002
814 BLOOD SODIUM DECREASED 4 0.0002
815 DIALYSIS 3 0.0002
816 LIP SWELLING 7 0.0002
817 ECZEMA 11 0.0002
818 SKIN DISORDER 7 0.0002
819 IMPAIRED QUALITY OF LIFE 3 0.0002
820 BLOOD GLUCOSE DECREASED 10 0.0002
821 ACUTE RESPIRATORY FAILURE 4 0.0002
822 VAGINAL HAEMORRHAGE 9 0.0002
823 MENTAL DISORDER 9 0.0002
824 APATHY 3 0.0002
825 ATRIAL FIBRILLATION 20 0.0002
826 DRUG INTERACTION 32 0.0002
827 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
828 EPISTAXIS 15 0.0002
829 BURNING SENSATION 14 0.0002
830 BLOOD POTASSIUM DECREASED 6 0.0002
831 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
832 PRODUCT COMPLAINT 5 0.0002
833 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
834 ALANINE AMINOTRANSFERASE INCREASED 12 0.0002
835 DEVICE RELATED INFECTION 3 0.0002
836 MUSCULOSKELETAL CHEST PAIN 3 0.0002
837 LUNG INFECTION 3 0.0002
838 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
839 PULMONARY HYPERTENSION 4 0.0002
840 DEAFNESS 5 0.0002
841 SPEECH DISORDER 10 0.0002
842 SEIZURE 22 0.0002
843 PRODUCT USE COMPLAINT 3 0.0002
844 SKIN EXFOLIATION 16 0.0002
845 OCULAR HYPERAEMIA 9 0.0002
846 NEUROPATHY PERIPHERAL 18 0.0002
847 MOOD SWINGS 6 0.0002
848 ABSCESS 3 0.0002
849 RETCHING 4 0.0002
850 SENSORY DISTURBANCE 3 0.0002
851 THROMBOSIS 15 0.0002
852 BALANCE DISORDER 16 0.0002
853 FAECES DISCOLOURED 4 0.0002
854 LIMB INJURY 5 0.0002
855 OROPHARYNGEAL PAIN 17 0.0002
856 PNEUMONITIS 5 0.0002
857 MOOD ALTERED 5 0.0002
858 URINARY TRACT INFECTION 31 0.0002
859 PHOTOSENSITIVITY REACTION 3 0.0002
860 DEHYDRATION 24 0.0002
861 TOOTH DISORDER 4 0.0002
862 RASH MACULO-PAPULAR 4 0.0002
863 RENAL IMPAIRMENT 15 0.0002
864 ANAEMIA 34 0.0002
865 FACE OEDEMA 3 0.0002
866 TARDIVE DYSKINESIA 5 0.0002
867 CHROMATURIA 4 0.0002
868 FLUSHING 18 0.0002
869 HEART RATE IRREGULAR 4 0.0002
870 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
871 CIRCULATORY COLLAPSE 3 0.0002
872 MUSCULOSKELETAL DISCOMFORT 3 0.0002
873 EYE IRRITATION 10 0.0002
874 MULTI-ORGAN FAILURE 3 0.0002
875 DYSKINESIA 7 0.0002
876 LOCAL SWELLING 3 0.0002
877 LIVER FUNCTION TEST ABNORMAL 5 0.0002
878 UNEVALUABLE EVENT 13 0.0002
879 DYSSTASIA 5 0.0002
880 DYSPHONIA 10 0.0002
881 INFLUENZA 19 0.0002
882 ASCITES 5 0.0002
883 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
884 ACUTE MYOCARDIAL INFARCTION 5 0.0002
885 LYMPHADENOPATHY 6 0.0002
886 DRUG EFFECT DECREASED 9 0.0002
887 APHASIA 5 0.0002
888 EMOTIONAL DISTRESS 20 0.0002
889 NEOPLASM MALIGNANT 11 0.0002
890 BONE DISORDER 3 0.0002
891 ENCEPHALOPATHY 4 0.0002
892 ABASIA 4 0.0002
893 CARDIAC FAILURE CONGESTIVE 13 0.0002
894 NEUTROPENIA 22 0.0002
895 AGEUSIA 4 0.0002
896 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
897 ANGIOEDEMA 7 0.0002
898 BLOOD URINE PRESENT 3 0.0002
899 GASTRIC ULCER 3 0.0002
900 HERPES ZOSTER 9 0.0002
901 POST PROCEDURAL COMPLICATION 3 0.0002
902 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
903 BONE PAIN 9 0.0002
904 SKIN FISSURES 3 0.0002
905 DERMATITIS ATOPIC 8 0.0002
906 SYNCOPE 15 0.0001
907 COGNITIVE DISORDER 7 0.0001
908 EYE PRURITUS 5 0.0001
909 PAIN OF SKIN 4 0.0001
910 INTENTIONAL SELF-INJURY 3 0.0001
911 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
912 BLOOD BILIRUBIN INCREASED 4 0.0001
913 HAEMATURIA 5 0.0001
914 TOOTH LOSS 3 0.0001
915 NEOPLASM PROGRESSION 5 0.0001
916 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
917 EATING DISORDER 3 0.0001
918 INTENTIONAL DOSE OMISSION 4 0.0001
919 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
920 CARDIAC DISORDER 13 0.0001
921 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
922 NEEDLE ISSUE 4 0.0001
923 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
924 MELAENA 3 0.0001
925 BLOOD PRESSURE DECREASED 9 0.0001
926 RENAL INJURY 4 0.0001
927 HOT FLUSH 10 0.0001
928 HEPATIC FAILURE 4 0.0001
929 SKIN DISCOLOURATION 6 0.0001
930 PERICARDIAL EFFUSION 3 0.0001
931 DRY SKIN 17 0.0001
932 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
933 ABNORMAL BEHAVIOUR 5 0.0001
934 DRUG DEPENDENCE 20 0.0001
935 CEREBROVASCULAR ACCIDENT 21 0.0001
936 BLINDNESS 5 0.0001
937 OSTEONECROSIS OF JAW 3 0.0001
938 EXTRAPYRAMIDAL DISORDER 3 0.0001
939 VISUAL ACUITY REDUCED 4 0.0001
940 VIRAL INFECTION 4 0.0001
941 COVID-19 21 0.0001
942 INJECTION SITE PRURITUS 8 0.0001
943 CARDIOVASCULAR DISORDER 3 0.0001
944 ACUTE KIDNEY INJURY 18 0.0001
945 HYPOPHAGIA 3 0.0001
946 SEPSIS 13 0.0001
947 RASH MACULAR 4 0.0001
948 THROAT TIGHTNESS 3 0.0001
949 DRUG EFFECT INCOMPLETE 4 0.0001
950 CRYING 4 0.0001
951 INFLUENZA LIKE ILLNESS 9 0.0001
952 OXYGEN SATURATION DECREASED 6 0.0001
953 ACNE 8 0.0001
954 MULTIPLE SCLEROSIS 5 0.0001
955 PRODUCT DOSE OMISSION ISSUE 30 0.0001
956 CATARACT 6 0.0001
957 INJECTION SITE BRUISING 8 0.0001
958 PREMATURE BABY 3 0.0001
959 INJECTION SITE RASH 3 0.0001
960 FEMUR FRACTURE 3 0.0001
961 RHABDOMYOLYSIS 4 0.0001
962 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
963 BRADYCARDIA 5 0.0001
964 PLATELET COUNT DECREASED 10 0.0001
965 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
966 PANCYTOPENIA 5 0.0001
967 NEPHROLITHIASIS 4 0.0001
968 PRODUCT SUBSTITUTION ISSUE 5 0.0001
969 SURGERY 5 0.0001
970 CEREBRAL HAEMORRHAGE 3 0.0001
971 INJECTION SITE ERYTHEMA 10 0.0001
972 HEPATIC FUNCTION ABNORMAL 3 0.0001
973 BLOOD GLUCOSE INCREASED 15 0.0001
974 MYOCARDIAL INFARCTION 13 0.0001
975 LUNG NEOPLASM MALIGNANT 3 0.0001
976 DEPENDENCE 4 0.0001
977 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
978 INJECTION SITE PAIN 22 0.0001
979 WITHDRAWAL SYNDROME 3 0.0001
980 DRUG WITHDRAWAL SYNDROME 6 0.0001
981 HYPOGLYCAEMIA 3 0.0001
982 THERAPY INTERRUPTED 4 0.0001
983 DEVICE ISSUE 5 0.0001
984 INJECTION SITE SWELLING 4 0.0001
985 DISEASE PROGRESSION 6 0.0001
986 DEVICE MALFUNCTION 3 0.0000
987 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
988 CARDIAC FAILURE 3 0.0000
989 DRUG DOSE OMISSION 6 0.0000